Covid and Vascular System, Endothelium, Blood Clots

Covid and Vascular System, Endothelium, Blood Clots

Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records
Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records
A first COVID-19 infection in children & teens increases the risk of blood clots, myocarditis, pericarditis, and inflammatory conditions, highest in the first week, with some risks lasting up to 12 months.
·thelancet.com·
Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records
Thread by @ZdenekVrozina on Thread Reader App
Thread by @ZdenekVrozina on Thread Reader App

“A possible new diagnostic approach to Long COVID. Long COVID may involve microcirculatory blockages - tiny, persistent clots known as fibrinaloid microclots. These abnormal fibrin structures resist breakdown and can obstruct blood flow in the smallest vessels.🧵”

·threadreaderapp.com·
Thread by @ZdenekVrozina on Thread Reader App
Thread by @ZdenekVrozina on Thread Reader App
Thread by @ZdenekVrozina on Thread Reader App

“COVID-19 doesn’t just cause inflammation. It switches off the genes that repair blood vessels - and switches on those that drive inflammation and destruction. And what’s worse - this state lasts for at least six months, long after the infection is gone🧵”

COVID-19 doesn’t just cause inflammation. It switches off the genes that repair blood vessels - and switches on those that drive inflammation and destruction. And what’s worse - this state lasts for at least six months, long after the infection is gone🧵
·threadreaderapp.com·
Thread by @ZdenekVrozina on Thread Reader App
Transcriptomic Profiling of Endothelial Progenitor Cells in Post-COVID-19 Patients: Insights at 3 and 6-Months Post-Infection
Transcriptomic Profiling of Endothelial Progenitor Cells in Post-COVID-19 Patients: Insights at 3 and 6-Months Post-Infection

“Our findings corroborate and expand upon existing evidence of endothelial dysfunction in COVID-19 patients, demonstrating decreased angiogenesis capacity, increased apoptosis, and oxidative stress."

“This confirms persistent endothelial damage after recovery”

·sciencedirect.com·
Transcriptomic Profiling of Endothelial Progenitor Cells in Post-COVID-19 Patients: Insights at 3 and 6-Months Post-Infection
COVID-19 Could Alter Your Blood Vessels, Finds New Study
COVID-19 Could Alter Your Blood Vessels, Finds New Study
“Six months after infection, all formerly Covid-positive groups showed stiffer arteries compared with the control group. The level of artery stiffness was notable ‘regardless of disease severity”—meaning, even milder Covid cases could later experience the effect”
·flip.it·
COVID-19 Could Alter Your Blood Vessels, Finds New Study
Circulating Microclots Are Structurally Associated With Neutrophil Extracellular Traps and Their Amounts Are Elevated in Long COVID Patients
Circulating Microclots Are Structurally Associated With Neutrophil Extracellular Traps and Their Amounts Are Elevated in Long COVID Patients

Stellenbosch University and Montpellier researchers studied 50 Long COVID patients and found their blood carried far more microclots tied to neutrophil immune traps.

These sticky structures may stabilize clots and help explain persistent symptoms.

·onlinelibrary.wiley.com·
Circulating Microclots Are Structurally Associated With Neutrophil Extracellular Traps and Their Amounts Are Elevated in Long COVID Patients
The main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII
The main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII

A new study shows that adding SARS-CoV-2’s main protease (Mpro) enzyme to plasma from healthy donors can trigger blood clots by activating coagulation factors VII and XII.

This may explain Covid’s common blood clot risk.

·nature.com·
The main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII
SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins
SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins
“what and how SARS-CoV-2 factors make endothelial cells (ECs) sensitive to complement-mediated cytotoxicity.”
what and how SARS-CoV-2 factors make endothelial cells (ECs) sensitive to complement-mediated cytotoxicity.
·tandfonline.com·
SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins
Evaluation of Function and Biochemical Parameters of Platelet Concentrates (PCs) Prepared From Blood Donors With a History of COVID‐19 During the Platelet Storage
Evaluation of Function and Biochemical Parameters of Platelet Concentrates (PCs) Prepared From Blood Donors With a History of COVID‐19 During the Platelet Storage
"Platelet concentrates (PCs) prepared from donors who recently recovered from COVID-19 demonstrated impaired platelet aggregation."
·onlinelibrary.wiley.com·
Evaluation of Function and Biochemical Parameters of Platelet Concentrates (PCs) Prepared From Blood Donors With a History of COVID‐19 During the Platelet Storage
Risk of blood clots remains for almost a year after COVID-19 infection, study suggests
Risk of blood clots remains for almost a year after COVID-19 infection, study suggests
“COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.”
COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.
·bristol.ac.uk·
Risk of blood clots remains for almost a year after COVID-19 infection, study suggests
SARS-CoV-2 pseudovirus dysregulates hematopoiesis and induces inflammaging of hematopoietic stem and progenitor cells - Experimental & Molecular Medicine
SARS-CoV-2 pseudovirus dysregulates hematopoiesis and induces inflammaging of hematopoietic stem and progenitor cells - Experimental & Molecular Medicine
“SARS-CoV-2) infection primarily affects the respiratory system but may induce hematological alterations such as anemia, lymphopenia and thrombocytopenia. Previous studies have reported that SARS-CoV-2 efficiently infects hematopoietic stem and progenitor cells (HSPCs); however, the subsequent effects on hematopoiesis and immune reconstitution have not yet been described. Here we evaluated the pathological effects of infection of umbilical-cord-blood-derived HSPCs”
·flip.it·
SARS-CoV-2 pseudovirus dysregulates hematopoiesis and induces inflammaging of hematopoietic stem and progenitor cells - Experimental & Molecular Medicine
ACE-2-like Enzymatic Activity in COVID-19 Convalescent Patients with Persistent Pulmonary Symptoms Associated with Immunoglobulin
ACE-2-like Enzymatic Activity in COVID-19 Convalescent Patients with Persistent Pulmonary Symptoms Associated with Immunoglobulin

Researchers at the University of Virginia found that some COVID-19 survivors produce antibodies that mimic ACE2 enzyme activity.

These may disrupt blood pressure regulation and contribute to Long COVID symptoms.

·medrxiv.org·
ACE-2-like Enzymatic Activity in COVID-19 Convalescent Patients with Persistent Pulmonary Symptoms Associated with Immunoglobulin
SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events | Radiology
SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events | Radiology
“Covid associated with acceleration of coronary atherosclerosis and developing high-risk plague, adverse cardiovascular events, by serial CCTA in over 800 participants and controls.”
·pubs.rsna.org·
SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events | Radiology
SARS-CoV-2 S-protein expression drives syncytia formation in endothelial cells
SARS-CoV-2 S-protein expression drives syncytia formation in endothelial cells
US researchers found that SARS-CoV-2 spike protein causes endothelial cells to fuse into syncytia, weakening blood vessel barriers and potentially worsening COVID-19 complications.
·nature.com·
SARS-CoV-2 S-protein expression drives syncytia formation in endothelial cells
The science of this Aug 2024 paper about was known clinically in Jan 2020 (attached paper).
The science of this Aug 2024 paper about was known clinically in Jan 2020 (attached paper).

The science of this Aug 2024 paper about #Covid was known clinically in Jan 2020 (attached paper).

If doctors had just read the literature & altered their treatment, millions of people would not have died.

When fibrin is being formed in the body a protein called D-dimer is made and can be measured in a blood sample.

This paper first published January 30, 2000 found D-dimer increased in 36% of patients, the sickest.

·x.com·
The science of this Aug 2024 paper about was known clinically in Jan 2020 (attached paper).
I’ve never seen patients in their 20’s and 30’s with DVT’s until the past few years. It’s unspeakably messed up.
I’ve never seen patients in their 20’s and 30’s with DVT’s until the past few years. It’s unspeakably messed up.

“I’ve never seen patients in their 20’s and 30’s with DVT’s until the past few years. It’s unspeakably messed up.

Not too long ago, saw yet another, this time un-vax’d.

@RandPaul End gain of function and have Nuremberg trials for the sociopaths who did this.”

·x.com·
I’ve never seen patients in their 20’s and 30’s with DVT’s until the past few years. It’s unspeakably messed up.
Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells
Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells
“summary, our results provided a detailed and comprehensive characterization of the vascular inflammatory effects of SARS-CoV-2. We showed that the endothelium plays an essential role in determining the outcome of COVID-19 infection, such as vascular inflammation and systemic organ damage during and possibly beyond the acute infection phase.”
·link.springer.com·
Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds
“COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds”
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds
·fortune.com·
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds